A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects

NCT07446153 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: HRS-8364 Tablet

Sponsor

Jiangsu HengRui Medicine Co., Ltd.